[1]
“Molecular Docking and Drug Kinetics Assessment for Structure-Based Drug Design of New Piperazine-Containing Hydrazone Derivatives as Effective Alzheimer Inhibitors”, J Biochem Microbiol Biotechnol, vol. 12, no. 2, pp. 37–43, Dec. 2024, doi: 10.54987/jobimb.v12i2.1016.